Advertisement

Topics

BioPortfolio Blog about Biotechnology, Pharmaceutical and Healthcare

15:18 EDT 25th September 2016 | BioPortfolio

Updates and info from the contributors bringing you BioPortfolio.com.

Showing News Articles 1–5 of 2,100+

Sunday 25th September 2016

Allergan wins Fda approval to market new Natrelle Inspira Cohesive breast implants

Allergan plc today announced the company has received approval from the U.S. Food and Drug Administration to market NATRELLE INSPIRA Cohesive breast implants, offering women undergoing reconstruction, augmentation or revision surgery a new breast shaping option that combines a high gel fill ratio and Allergan's highly cohesive gel for a customized result. The new NATRELLE INSPIRA Cohesive line...

Saturday 24th September 2016

LiGNO Introduces Tiger Milk Mushroom As Health Supplement

Saturday, 24 September 2016 By Harizah Hanim Mohamed KUALA LUMPUR, Sept 24 -- A mushroom cultivation biotechnology firm, LiGNO Biotech Sdn Bhd, aims to introduce its Tiger Milk Mushroom as a daily health supplement in temperate nations including the United States and Europe. Chief Executive Officer Ng Szu Ting said the company was looking forward to diversify its product range in the near future b...

The maker of EpiPen kept repeating one stat to Congress

On Wednesday Heather Bresch, the CEO of Mylan, the company that makes EpiPens, appeared before Congress to explain why her company raised the price of the lifesaving drug 500%, causing public outrage.

A biotech startup is trying to end poaching by 'flooding the market' with fake rhino horns

File photo of a rhino after it was dehorned in an effort to deter the poaching of one of the world's endangered species, at a farm outside Klerksdorp, South Africa. hey're used to make elaborate carvings across East Asia and also believed to have curative properties in some traditional Eastern medicines, despite a lack of evidence .

Bank of Montreal Can Takes Position in Mylan Inc.

Bank of Montreal Can bought a new stake in shares of Mylan Inc. during the second quarter, according to its most recent filing with the SEC. The firm bought 801,770 shares of the company's stock, valued at approximately $34,668,000.


Quick Search
Advertisement